CASI Pharmaceuticals Q3 EPS $(0.1), Same YoY

CASI Pharmaceuticals (NASDAQ:CASI) reported quarterly losses of $(0.1) per share. This is unchanged from the same period last year.

Benzinga · 11/12/2019 12:09

CASI Pharmaceuticals (NASDAQ:CASI) reported quarterly losses of $(0.1) per share. This is unchanged from the same period last year.